Grant: Engage Grants Program
University of Alberta
$25,000.00
Supercritical carbon dioxide extraction of red clover isoflavones
EF 2012-13
Résumé
Despite the tremendous growth in the natural health products industry over the last couple of decades, there are
still challenges regarding standardization and traceability of the various herbal extracts. Sinoveda Canada Inc.
is an Alberta company, developing standardized nutraceutical and pharmaceutical products with proven
therapeutic efficacy based on a patent pending Pharmaceutical Platform Technology. A major target for
Sinoveda is red clover extracts for post-menopausal osteoporosis. They have identified specific ratios of two
key isoflavone compounds for effective dosages. Large scale production of such extracts with traceability
records is needed for further product development, testing and marketing. Supercritical carbon dioxide
(SC-CO2) extraction, using CO2 at temperature and pressure conditions above its critical point (31oC and 7.4
MPa), offers numerous advantages compared to conventional solvent extraction techniques in terms of
eliminating/reducing the use of organic solvents, ease of removal of CO2 upon depressurization and achieving
faster extraction rates. Therefore, the main objective of the proposed research project is to optimize the
SC-CO2 extraction parameters (temperature, pressure, co-solvent addition, flow rate, solvent-to-feed ratio and
time) in an effort to increase the isoflavone content of crude extracts to over 40% and to reach the targeted ratio
of the specific bioactive components. The extract fractions will be obtained using the laboratory-scale extractor
at the University of Alberta and composition analysis will be performed at Sinoveda. The two groups will be
working closely together to ensure timely transfer of knowledge and samples. The findings will establish the
basis for scale up and further product development. Developing such a processing technology combined with
the extensive pharmacological testing and standardization as well as demonstrated traceability will enhance the
position of Canadian natural health products in a very competitive global market place.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
429725-2012
Name nom
Temelli, Feral
Department département
Agricultural, Food and Nutritional Science
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
6103
Research subject group en
Food science and technology
Research subject group fr
Science et technologie de l'alimentation
Research subject en
Food processing, packaging, preservation and storage
Research subject fr
Transformation, conditionnement, conservation et stockage des aliments
Partie
1
Nb partie
1
Application title
Supercritical carbon dioxide extraction of red clover isoflavones
Keyword
NSERC
Application summary
Despite the tremendous growth in the natural health products industry over the last couple of decades, there are
still challenges regarding standardization and traceability of the various herbal extracts. Sinoveda Canada Inc.
is an Alberta company, developing standardized nutraceutical and pharmaceutical products with proven
therapeutic efficacy based on a patent pending Pharmaceutical Platform Technology. A major target for
Sinoveda is red clover extracts for post-menopausal osteoporosis. They have identified specific ratios of two
key isoflavone compounds for effective dosages. Large scale production of such extracts with traceability
records is needed for further product development, testing and marketing. Supercritical carbon dioxide
(SC-CO2) extraction, using CO2 at temperature and pressure conditions above its critical point (31oC and 7.4
MPa), offers numerous advantages compared to conventional solvent extraction techniques in terms of
eliminating/reducing the use of organic solvents, ease of removal of CO2 upon depressurization and achieving
faster extraction rates. Therefore, the main objective of the proposed research project is to optimize the
SC-CO2 extraction parameters (temperature, pressure, co-solvent addition, flow rate, solvent-to-feed ratio and
time) in an effort to increase the isoflavone content of crude extracts to over 40% and to reach the targeted ratio
of the specific bioactive components. The extract fractions will be obtained using the laboratory-scale extractor
at the University of Alberta and composition analysis will be performed at Sinoveda. The two groups will be
working closely together to ensure timely transfer of knowledge and samples. The findings will establish the
basis for scale up and further product development. Developing such a processing technology combined with
the extensive pharmacological testing and standardization as well as demonstrated traceability will enhance the
position of Canadian natural health products in a very competitive global market place.